For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

New York Stem Cell Foundation, Inc.

USPTO Granted Patents = 25

EPO Patents = 6

Trademarks = 2

Forward Citations = 32

Loading Chart...

Loading Chart...

20 inventors (with patents filed for the assignee):

Scott Noggle (12 out of 12 patents)

Stephen Chang (9 out of 11 patents)

Dietrich M Egli (8 out of 8 patents)

4. Susan L Solomon (6 out of 6 patents)

5. Kevin C Eggan (5 out of 10 patents)

6. Panagiotis Douvaras (4 out of 4 patents)

7. Valentina Fossati (4 out of 4 patents)

8. Giuseppe Maria De Peppo (3 out of 3 patents)

9. Kevin Eggan, Jr (2 out of 9 patents)

10. Nissim Benvenisty (2 out of 10 patents)

11. Ido Sagi (2 out of 2 patents)

12. Martina Sladkova (1 out of 1 patent)

13. Maitane Ortiz-Virumbrales (1 out of 1 patent)

14. Sam Gandy (1 out of 1 patent)

15. Ilya Kruglikov (1 out of 1 patent)

Core Competencies:

Neurodegenerative Disease

Induced Pluripotent Stem Cells

Microfluidic System

Haploid Stem Cell Lines

Oligodendrocytes

Tissue Grafts

Bone-Implant Grafts

Microglia

Bioreactor

Somatic Cell Nuclear Transfer

Modified Oocytes

Pluripotent Stem Cells

25 patents: Sort by Forward Citations

1. 12749178 - Methods and systems for predicting neurodegenerative disease state (2026-09-29),

2. 12698479 - Automated system for producing induced pluripotent stem cells or differentiated cells (2026-08-04),

3. 12247195 - Microfluidic system and method of use thereof (2025-03-11),

4. 12091678 - Haploid human embryonic stem cell lines and somatic cell lines and methods of making the same (2024-09-17),

5. 11814648 - Functional oligodendrocytes derived from pluripotent stem cells and methods of making and using the same (2023-11-14),

6. 11732242 - Automated system for producing induced pluripotent stem cells or differentiated cells (2023-08-22),

7. 11542465 - Microfluidic system and method of use thereof (2023-01-03),

8. 11471285 - Tissue grafts and methods of making and using the same (2022-10-18),

9. 11357890 - Customized hybrid bone-implant grafts (2022-06-14),

10. 11149250 - Microglia derived from pluripotent stem cells and methods of making and using the same (2021-10-19),

11. 11136556 - Systems and methods for producing stem cells and differentiated cells (2021-10-05),

12. 10968435 - Automated system for producing induced pluripotent stem cells or differentiated cells (2021-04-06),

13. 10961503 - Haploid human embryonic stem cell lines and somatic cell lines and methods of making the same (2021-03-30),

14. 10947562 - Methods for making and using modified oocytes (2021-03-16),

15. 10889800 - Method and composition for generating basal forebrain cholinergic neurons (BFCNS) (2021-01-12),

Company Overview

The New York Stem Cell Foundation, Inc. is a leading organization dedicated to advancing stem cell research and its applications in regenerative medicine. Based in New York, the foundation focuses on funding innovative research projects that aim to unlock the potential of stem cells for treating various diseases and conditions. By fostering collaboration among scientists and providing resources for groundbreaking studies, NYSCF plays a pivotal role in translating scientific discoveries into therapeutic solutions, enhancing the future of healthcare.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

25 Patents

#339 in New York, NY

#788 in New York

#13,364 in US

#25,710 in the World

New York, NY, United States of America

New York Stem Cell Foundation, Inc.

Forward Citations = 32

20 inventors:

Scott Noggle (12 out of 12 patents)

Stephen Chang (9 out of 11 patents)

Dietrich M Egli (8 out of 8 patents)

4. Susan L Solomon (6 out of 6 patents)

5. Kevin C Eggan (5 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: New York Stem Cell Foundation, Inc.. Retrieved from https://idiyas.com/company/new-york-stem-cell-foundation

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…